DECADE: Impact of Diverticular Disease on the Detection of Colon Adenomas

Sponsor
Technische Universität München (Other)
Overall Status
Unknown status
CT.gov ID
NCT02057562
Collaborator
(none)
1,000
2
36.9
500
13.5

Study Details

Study Description

Brief Summary

Benign adenomas of the colon have the potential to degenerate and become malignant. Therefore adenomatous polyps should be detected and resected during colonoscopy. Factors like advanced age and male gender are associated with the detection of adenomas. The same epidemiological pattern can be found with regard to colon diverticula. Furthermore, western world countries report higher incidences of both colorectal carcinoma as well as diverticular disease. It is not known whether a correlation exists between both entities. Some recent data have postulated higher adenoma detection rates in patients with concomitant diverticular disease (Rondagh EJ et al. Eur J Gastroenterol Hepatol. 2011; 23:1050-5. Kieff BJ et al. Am J Gastroenterol 2004; 99: 2007-11). If a positive correlation could be found this would possibly affect recommendations regarding colonoscopy surveillance intervals for patients with and without diverticular disease. The investigators therefore plan to conduct the following trial.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Study Start Date :
    Feb 1, 2014
    Actual Primary Completion Date :
    Sep 1, 2016
    Anticipated Study Completion Date :
    Mar 1, 2017

    Arms and Interventions

    Arm Intervention/Treatment
    Routine colonoscopy

    Patients receiving routine colonoscopy (for a multitude of indications) at the study centers are eligible for participation

    Outcome Measures

    Primary Outcome Measures

    1. Adenoma detection rate [up to 2 weeks (participants will be followed for the duration of hospital stay or outpatient treatment, an expected average of 2 weeks)]

      After obtaining the histopathological diagnosis of resected polyps (approximately 3 days - 2 weeks after colonoscopy ) accuracy of optical diagnosis can be determined

    Secondary Outcome Measures

    1. Polyp detection rate [up to one day]

      a maximum of one day is expected for colonoscopy

    2. Frequency of colon diverticulosis [up to one day]

      a maximum of one day is expected for colonoscopy

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • indication for colonoscopy

    • age >= 18 years

    Exclusion Criteria:
    • pregnant women

    • patients denying written consent

    • indication for colonoscopy: familial adenomatous polypose

    • indication for colonoscopy: inflammatory bowel disease

    • indication for colonoscopy: previously known colon polyp/adenoma/carcinoma

    • history of colon surgery

    • contraindication for resection of polyps

    • American Society of Anesthesiologists (ASA) class IV, V or VI

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Rotkreuzklinikum München München Deutschland Germany 80634
    2 II Medizinische Klinik am Klinikum rechts der Isar der Technischen Universität München München Deutschland Germany 81677

    Sponsors and Collaborators

    • Technische Universität München

    Investigators

    • Principal Investigator: Peter Klare, MD, II. Medizinische Klinik, Klinikum rechts der Isar der Technischen Universität München, Germany
    • Study Chair: Peter Born, Prof. Dr., Innere Medizin II, Rotkreuzklinikum München, Nymphenburger Str. 163, München, Germany
    • Study Director: Stefan von Delius, MD, II. Medizinische Klinik, Klinikum rechts der Isar der Technischen Universität München, Germany

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dr. Peter Klare, MD, Technische Universität München
    ClinicalTrials.gov Identifier:
    NCT02057562
    Other Study ID Numbers:
    • DECADE
    First Posted:
    Feb 7, 2014
    Last Update Posted:
    Nov 21, 2016
    Last Verified:
    Nov 1, 2016
    Keywords provided by Dr. Peter Klare, MD, Technische Universität München
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 21, 2016